Inhibition of the eukaryotic initiation factor-2α kinase PERK decreases risk of autoimmune diabetes in mice
Charanya Muralidharan(University of Chicago), Raghavendra G. Mirmira(University of Chicago)
Cited by 18
Related Papers
Pancreatic beta cell autophagy is impaired in type 1 diabetes
|Diabetologia|2021|97
12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice
|JCI Insight|2024|8
Inhibition of the Eukaryotic Initiation Factor-2-α Kinase PERK Decreases Risk of Autoimmune Diabetes in Mice
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1
12-Lipoxygenase inhibition delays onset of autoimmune diabetes in human gene replacement mice
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1